Non-amine-based dopamine transporter (reuptake) inhibitors retain properties of amine-based progenitors.
Madras BK, Fahey MA, Miller GM, De La Garza R, Goulet M, Spealman RD, Meltzer PC, George SR, O'Dowd BF, Bonab AA, Livni E, Fischman AJ.
Madras BK, et al. Among authors: fahey ma.
Eur J Pharmacol. 2003 Oct 31;479(1-3):41-51. doi: 10.1016/j.ejphar.2003.08.055.
Eur J Pharmacol. 2003.
PMID: 14612136